Jia Jie Biomedical Co., Ltd. (TPEX:4109)

Market Cap	1.40B -29.0%
Revenue (ttm)	485.40M -9.6%
Net Income	50.26M -76.2%
EPS	0.43 -80.0%
Shares Out	118.74M
PE Ratio	27.44
Forward PE	n/a
Dividend	0.20 (1.69%)
Ex-Dividend Date	n/a

Volume	393,029
Average Volume	194,269
Open	11.80
Previous Close	11.90
Day's Range	11.75 - 12.00
52-Week Range	11.75 - 18.80
Beta	0.06
RSI	27.39
Earnings Date	Apr 2, 2026

About Jia Jie Biomedical

Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules; and import and export, distribution, bidding, quotation of the products. It also involved in the wholesa...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1995
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4109

Financial Performance

In 2025, Jia Jie Biomedical's revenue was 485.40 million, a decrease of -9.62% compared to the previous year's 537.07 million. Earnings were 50.26 million, a decrease of -76.22%.